Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 475

    1.

    Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.

    Albrektsen T, Frederiksen KS, Holmes WE, Boel E, Taylor K, Fleckner J.

    Diabetes. 2002 Apr;51(4):1042-51.PMID: 11916924 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.

    Gerhold DL, Liu F, Jiang G, Li Z, Xu J, Lu M, Sachs JR, Bagchi A, Fridman A, Holder DJ, Doebber TW, Berger J, Elbrecht A, Moller DE, Zhang BB.

    Endocrinology. 2002 Jun;143(6):2106-18.PMID: 12021175 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.

    Tamori Y, Masugi J, Nishino N, Kasuga M.

    Diabetes. 2002 Jul;51(7):2045-55.PMID: 12086932 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The transcription factor Fos-related antigen 1 is induced by thiazolidinediones during differentiation of 3T3-L1 cells.

    Albrektsen T, Fleckner J.

    Mol Pharmacol. 2001 Mar;59(3):567-75.PMID: 11179452 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.

    Rieusset J, Touri F, Michalik L, Escher P, Desvergne B, Niesor E, Wahli W.

    Mol Endocrinol. 2002 Nov;16(11):2628-44. Erratum in: Mol Endocrinol 2002 Dec;16(12):2745. PMID: 12403851 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake.

    Hamm JK, el Jack AK, Pilch PF, Farmer SR.

    Ann N Y Acad Sci. 1999 Nov 18;892:134-45.PMID: 10842659 [PubMed - indexed for MEDLINE]Related articles

    8.

    Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes.

    Takamura T, Nohara E, Nagai Y, Kobayashi K.

    Eur J Pharmacol. 2001 Jun 22;422(1-3):23-9.PMID: 11430909 [PubMed - indexed for MEDLINE]Related articles

    9.

    A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.

    Mukherjee R, Hoener PA, Jow L, Bilakovics J, Klausing K, Mais DE, Faulkner A, Croston GE, Paterniti JR Jr.

    Mol Endocrinol. 2000 Sep;14(9):1425-33.PMID: 10976920 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

    Vidal-Puig A, Jimenez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE.

    J Clin Invest. 1996 Jun 1;97(11):2553-61.PMID: 8647948 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity.

    Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD, Thieringer R.

    J Biol Chem. 2001 Apr 20;276(16):12629-35. Epub 2001 Jan 22.PMID: 11278270 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.

    Ruan H, Pownall HJ, Lodish HF.

    J Biol Chem. 2003 Jul 25;278(30):28181-92. Epub 2003 May 5.PMID: 12732648 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2.

    Li Y, Lazar MA.

    Mol Endocrinol. 2002 May;16(5):1040-8.PMID: 11981038 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.

    Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, Leff T.

    Diabetes. 2000 Apr;49(4):539-47.PMID: 10871190 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.

    Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, Moller DE.

    Mol Endocrinol. 1996 Nov;10(11):1457-66.PMID: 8923470 [PubMed - indexed for MEDLINE]Related articles

    18.

    Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.

    Kallen CB, Lazar MA.

    Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5793-6.PMID: 8650171 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.

    Kast-Woelbern HR, Dana SL, Cesario RM, Sun L, de Grandpre LY, Brooks ME, Osburn DL, Reifel-Miller A, Klausing K, Leibowitz MD.

    J Biol Chem. 2004 Jun 4;279(23):23908-15. Epub 2004 Apr 8.PMID: 15073165 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.

    Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Pories WJ, Caro JF, Flier JS.

    J Clin Invest. 1997 May 15;99(10):2416-22.PMID: 9153284 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data